KeyMed Statements
21
Data from KeyMed`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
CNY - Chinese yuan
Last reporting period:
30 Jun, 2022
Next reporting period:
27 Dec, 2022
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
22 Aug, 2024
KeyMed Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
100
-9.3 %
100
2.537
2.5
97.463
4.7 %
97.5
164.01
164
51.048
51
201.75
-43.3 %
201.8
-104.29
60.3 %
-104.3
106.82
106.8
—
0
2.524
101 %
2.5
—
0
5.454
102.1 %
5.5
0.02
267.34
110.27
—
100
17.2
15.6
93.069
—
84.4
167.09
151.5
65.618
59.5
355.86
-90.1 %
322.7
-262.79
92.7 %
-238.3
-10.729
-9.7
—
0
-262.2
92.8 %
-237.8
—
0
-258.81
92.9 %
-234.7
-5.104
50.702
—
—
100
—
0
—
—
0
191.06
0
26.836
0
3 608.57
—
0
-3 608.57
—
0
5.89
0
—
0
-3 630.43
—
0
—
0
-3 628.5
—
0
-13.389
271